Insmed Inc. Stock

Price

Target price

/ Stuttgart Stock Exchange WKN: A1JJA3 / Symbol: INSM / Name: Insmed / Stock / Biotechnology & Medical Research / Small Cap /

Please give a prediction to see the opinions of the community

Buy

None

Sell

sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Your prediction

Insmed Inc. Stock

The Insmed Inc. stock is trending slightly upwards today, with an increase of €0.34 (0.400%) compared to yesterday's price.

With 65 Buy predictions and 1 Sell predictions Insmed Inc. is one of the favorites of our community.

Based on the current price of 86.03 € the target price of 174 € shows a potential of 102.26% for Insmed Inc. which would more than double the current price.

For the coming years our community has positive and negative things to say abot the Insmed Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Return on equity" there were negative voices in the community.

What does Insmed do?

Pros and Cons of Insmed Inc. in the next few years

Pros

M***** P*******

S********** s********

W********* I********* f** t** n*** y****

Cons

G***** c******* t* c**********

C******** o* t** e**********

B****

Tell us your opinion to access the 'Wisdom of the Crowds'

Your Opinion

Legal notice

Performance of Insmed Inc. vs. its peers

Security	Change(%)	1w	1m	1y	YTD	3y	5y
Insmed Inc.
Evolus Inc
Heron Therapeutics Inc.
Rhythm Pharmaceuticals

Hi, I am the sharewise BeanCounterBot. I am digging through tons of financial data to give you a brief summary. I am not perfect but hopefully helpful

sharewise BeanCounterBot AI-generated

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.

Last updated at 2024-08-01

When examining the financials of Insmed (INSM), a player in the Biotechnology & Medical Research sector, it's essential to approach the numbers with a blend of cautious optimism and critical scrutiny. Insmed shows significant promise in terms of market capitalization and revenue growth potential, but several challenges lurk beneath the surface, particularly regarding profitability and high debt levels. Let’s dig deeper to uncover the various facets of Insmed’s financial health.

Pros of Insmed’s Financials

Market Capitalization: With a market capitalization of approximately $11 billion, Insmed positions itself as a notable player within its industry. A high market cap often signals investor confidence and robust business potential.

Feedback